Journal session : Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Fellow : Worawong C.
9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit
http://www.idchula.org/______________________________________________
Dissaruj Tovikkai,MD
นพ.ดิษรุจ โตวิกกัย
